Back to search

Article

Specialty Care and Counselling about Hereditary Cancer Risk Improves Adherence to Cancer Screening and Prevention in Newfoundland and Labrador Patients with <em>BRCA1/2</em> Pathogenic Variants: A Population-Based Retrospective Cohort Study

2023-09-19

Abstract excerpt

BRCA1 and 2 pathogenic variants increase lifetime risks of breast (50-75%) and ovarian cancer (15-20%). Guidelines recommend breast screening (MRI and mammogram) or risk-reducing mastectomy with salpingo-oophorectomy for ovarian cancer prevention. We sought to 1) characterize the population of BRCA1/2 carriers in Newfoundland and Labrador (NL) 2) evaluate risk-reducing interventions 3) identify factors influencing...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f1e7bba4-6767-5655-9c32-56becce2406a
DOI
10.20944/preprints202309.1207.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Specialty Care and Counselling about Hereditary Cancer Risk Improves Adherence to Cancer Screening and Prevention in Newfoundland and Labrador Patients with <em>BRCA1/2</em> Pathogenic Variants: A Population-Based Retrospective Cohort StudyDOI 10.20944/preprints202309.1207.v1
Specialty Care and Counselling about Hereditary Cancer Risk Improves Adherence to Cancer Screening and Prevention in Newfoundland and Labrador Patients with BRCA1/2 Pathogenic Variants: A Population-Based Retrospective Cohort Study.Semantic proximity
Suboptimal Adherence to Hereditary Cancer Risk Management Guidelines: A Cohort Study of High-Risk Individuals in Newfoundland and Labrador, Canada.Semantic proximity
Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation.Semantic proximity
Uptake of Screening and Risk Reducing Recommendations Among Women with Hereditary Breast and Ovarian Cancer Syndrome Evaluated at a Large Urban Comprehensive Cancer CenterSemantic proximity
Uptake of risk-reducing medical interventions among female BRCA1/2 pathogenic variant carriers: A population-based study in British Columbia.Semantic proximity
Cancer prevention in cancer predisposition syndromes: A protocol for testing the feasibility of building a hereditary cancer research registry and nurse navigator follow up model.Semantic proximity
Hereditary ovarian cancer risk reduction: a retrospective evaluation of patient perspectives and service provision at a regional hereditary gynaecologic cancer clinic 2006-2016.Semantic proximity
Selected Medical Interventions in Women With a Deleterious Brca Mutation: A Population-Based Study in British ColumbiaSemantic proximity
Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics.Semantic proximity
Real-world health services utilisation and outcomes after BRCA1 and BRCA2 testing in Ontario, Canada: the What Comes Next Cohort Study protocol.Semantic proximity
Uptake of screening and risk-reducing recommendations among women with hereditary breast and ovarian cancer syndrome due to pathogenic BRCA1/2 variants evaluated at a large urban comprehensive cancer center.Semantic proximity
Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system.Semantic proximity
Select a neighboring publication to make it the new centre.